Brazil’s ANVISA Streamlines Medical Device Importation Processes
Questions? Request more information from our specialists
CONTACT USJan 19, 2018
EMERGO SUMMARY OF KEY POINTS:
- A new ANVISA resolution has simplified medical device importation requirements for Brazil.
- Imported devices no longer have to undergo inspections at Brazilian points of entry.
- Additional changes to simplify ANVISA importation requirements are anticipated in the near future.
Brazilian medical device market regulator ANVISA has simplified importation regulations to ease market entry for foreign manufacturers commercializing in the country.
Among other changes, ANVISA Resolution RDC 208/2018 (link in Portuguese) removes requirements that devices imported into Brazil must undergo inspection at sites where they receive product clearance, which should result in faster time to market for affected importers.
RDC 208/2018: Impact on medical device importers
Other important changes in the new resolution include:
- Changing deadlines for responses to importation queries to 30 days
- Labeling requirements that now differentiate information according to product class
- Device imports no longer require authentication and signature recognition following implementation of electronic signing and petitioning processes
- Importers must no longer link MERCOSUR Common Nomenclature (NCM) to particular procedures
Bottom line
According to Luiz Levy, Director of QA/RA at Emergo in Brazil, RDC 208/2018 will benefit foreign medical device manufacturers entering the Brazilian market in terms of time and cost.
“This is a great change that simplifies the importation process, helps reduce importation timeframes and reduces costs associated with importation,” Levy says. “We anticipate additional steps from ANVISA in the near future to simplify import licensing requirements using a risk-based approach, which should further benefit foreign manufacturers with good compliance histories.”
Related Brazilian medical device regulatory resources from Emergo:
- Brazil ANVISA medical device registration consulting
- Brazil Registration Holder (BRH) in-country representation
- Certificate of Free Sale (CFS) support for medical device exports
- Whitepaper: Medical device registration in Brazil
- Regulatory process chart: ANVISA approval for medical devices
Author
- Stewart Eisenhart
Related
Brazilian Regulators Establish Criteria for Marketing of Unregistered Medical Devices
EMERGO KEY POINTS:
- New Brazilian regulations list criteria for importing unregistered medical devices and health products into the country to address public health issues.
- Qualifying devices and products must be requested by the Brazilian Ministry of Health; requests are then reviewed by ANVISA.
Brazil’s ANVISA Proposing Easier Market Pathway for Low-risk Medical Devices and IVDs
EMERGO SUMMARY OF KEY POINTS:
- Brazil’s ANVISA plans to replace cadastro registration requirements for Class I medical devices and IVDs with a notification system for faster market access.
- Class I devices undergoing notification instead of cadastro review would bypass technical analysis.
- Additional public consultations and regulations will need to be published before ANVISA’s notification system comes into force.
ANVISA Provides More Details on New Brazilian GMP Inspection Regime
EMERGO SUMMARY OF KEY POINTS:
- Brazil’s ANVISA has published a new regulation to clarify changes to its Brazil GMP inspection and certification process.
- The regulation, RDC 183/2017, explains which documents are required for BGMP certification as well as which types of establishments that must obtain BGMP certification in Brazil.
- Applicants that submitted inspection requests before the new BGMP certification process was announced will have 60 days to file amendments to ANVISA to qualify for the new approach.